Michael G. Kurilla - Concepedia

Author

Michael G. Kurilla

Also Known As

Clare Schmitt, Girvin, Andrew T, M G Kurilla, M Kurilla, M.G. Kurilla, MICHAEL G. KURILLA, Meredith Temple-O’Connor, Michael G Kurilla, Michael G. Kurilla, Michael Kurilla

112

Publications

6.4K

Citations

H-Index

Concepts

All Affiliations

University of Virginia University of Birmingham Duke Medical Center Duke University Bristol-Myers Squibb (United States)

About

Michael G. Kurilla is an author at University of Virginia specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	32	4.8K
2	Natural Sciences	6	6	293
3	Allergy	4	4	719
4	Public Health	2	2	32
5	Health Sciences	1	1	13

Michael G. Kurilla

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1 Jelena Levitskaya, Michael Coram, Victor Levitsky, Nature ImmunologyInternal Repeat RegionPathologyVirologyAntiviral Response	1995	821
The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment Melissa Haendel, Christopher G. Chute, Tellen D. Bennett, Journal of the American Medical Informatics Association	2020	569
Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. R J Murray, Michael G. Kurilla, Jill Brooks, The Journal of Experimental Medicine Target AntigensImmunologyAntigen ProcessingCd4 T Cell ResponsesImmune System	1992	505
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. Rajiv Khanna, Scott R. Burrows, Michael G. Kurilla, The Journal of Experimental Medicine VaccinationTarget EpitopesUbiquitous Epstein-barr VirusVaccine DevelopmentVaccine Research	1992	390
Immediate Early and Early Lytic Cycle Proteins Are Frequent Targets of the Epstein-Barr Virus–induced Cytotoxic T Cell Response Neil Steven, Nicola Annels, Anita Kumar, The Journal of Experimental Medicine Ebv Disease PathogenesisImmunologyPathologyAntigen ProcessingImmediate Early	1997	349
Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1 Christian Münz, Kara Bickham, Marion Subklewe, The Journal of Experimental Medicine Immunological MemoryAutoimmune DiseaseEpstein-barr VirusAdaptive Immune SystemImmunology	2000	342
Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1 F. Wang, S F Tsang, Michael G. Kurilla, Journal of Virology Ebv Type 2Molecular VirologyEpstein-barr VirusImmunologyViral Pathogenesis	1990	309
Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. Victor Argaet, Christopher Schmidt, Scott R. Burrows, The Journal of Experimental Medicine Persistent InfectionSystems BiologyEpstein-barr VirusNeurovirologyMemory Response	1994	277
Human CD8 + T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)–Containing Protein Requires Exogenous Processing Neil Blake, Steven Lee, Irina Redchenko, Immunity Adaptive Immune SystemEbv Ebna1ImmunologyHla ClassAntigen Processing	1997	257
HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2 S P Lee, Wendy A. Thomas, R J Murray, Journal of Virology	1993	181

Page 1